Ligand-induced regulation of ERα and ERβ is indicative of human breast cancer cell proliferation

Breast Cancer Research and Treatment

Volumn 81, Issue 3, 2003, Pages 209-221

  Power, Krista A ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Estrogen receptors and ; Genistein; SERM; Tamoxifen

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; HUMANS; PROGNOSIS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0242298768     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026114501364     Document Type: Article

References (37)

1. Lawrence J, Malpas P, Sigman C, Kelloff G: Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal v.s. postmenopausal women. J Cell Biochem S34: 103-114, 2000
2. Casanova M, You L, Gaido K, Archibeque-Engle S, Janszen D, Heck H: Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daizein with rat ERα and ERβ in vitro. Toxicol Sci 51: 236-244, 1999
3. Jordan V: Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res Treat 31: 41-52, 1994
4. Russo J, Ao X, Grill C, Russo I: Pattern of distribution of cells positive for estrogen receptor a and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 53: 217-227, 1999
5. Goodson W, Moore D, Ljung B, Chew K, Mayall B, Smith H, Waldman F: The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67. Breast Cancer Res Treat 59: 113-123, 2000
6. Wiesen J, Young P, Werb Z, Cunha G: Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 126: 335-344, 1999
7. Kuiper G, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996
8. Osborne K: Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51: 227-238, 1998
9. Pavao M, Traish A: Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor α and β. Steroid 66: 1-16, 2001
10. Pettersson K, Delaunay F, Gustafsson J: Estrogen receptor β acts as a dominant regulator of estrogen signaling. Oncogene 19: 4970-4978, 2000
11. Jensen E, Cheng G, Palmieri C, Saji S, Mäkelä S, Van Noorden S, Wahlström T, Warner M, Coombes R, Gustafsson J: Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci USA 98: 15197-15202, 2001
12. Paech K, Webb P, Kuiper G, Nilsson S, Gustafsson J, Kushner P, Scanlan T: Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277: 1508-1510, 1997
13. Speirs V, Parkes A, Kerin M, Walton D, Carleton P, Fox J, Atkin S: Coexpression of estrogen receptor α and β: poor prognostic factors in human breast cancer? Cancer Res 59: 525-528, 1999
14. Neven P, Vergote I: Tamoxifen, screening and new oestrogen receptor modulators. Best Prac Res Cl Ob 15: 365-380, 2001
15. Fabian C: Who should receive which selective estrogen receptor modulator for prevention of breast cancer. Breast J 5: 211-214, 1999
16. McInerney E, Weis K, Sun J, Mosselman S, Katzenellenbogen B: Transcription activation by the human estrogen receptor subtype β (ERβ) studied with ERβ and ERα receptor chimeras. Endocrinology 139: 4513-4522, 1998
17. Speirs V, Malone C, Walton D, Kerin M, Atkin S: Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res 59: 5421-5424, 1999
18. Barnes S, Grubbs C, Setchell K, Carlson J: Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res 347: 239-253, 1990
19. Messina M, Loprinzi C: Soy for breast cancer survivors: a critical review of the literature. J Nutr 131: 3095S-3108S, 2001
20. Allred C, Allred K, Ju Y, Virant S, Helferich W: Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose dependent manner. Cancer Res 61: 5045-5050, 2001
21. Hsieh C, Santell R, Haslam S, Helferich W: Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58: 3833-3838, 1998
22. Zava D, Duwe G: Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27: 31-40, 1997
23. Wang T, Sathyamoorthy N, Phang J: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17: 271-275, 1996
24. Kuiper G, Lemmen J, Carlsson B, Corton J, Safe S, van der Saag P, van der Burg B, Gustafsson J: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139: 4252-4263, 1998
25. Vladusic E, Hornby A, Guerra-Vladusic F, Lakins J, Lupu R: Expression and regulation of estrogen receptor β in human breast tumors and cell lines. Oncol Rep 7: 157-167, 2000
26. Palmieri C, Cheng G, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Noorden S, Wahlstrom T, Coombes R, Warner, Gustafsson J: Estrogen receptor beta in breast cancer. Endocr-Relat-Cancer 9: 1-13, 2002
27. Gustafsson J, Warner M: Estrogen receptor β in the breast: role in estrogen responsiveness and development of breast cancer. J Steroid Biochem Mol Biol 74: 245-248, 2000
28. Jarvinen T, Pelto-Huikko M, Holli K, Isola J: Estrogen receptor beta is coexpressed with estrogen receptor alpha and PR and associated with nodal status grade, and proliferation rate in breast cancer. Am J Pathol 156: 29-35, 2000
29. Kuiper G, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson.S, Gustafsson J: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology, 138: 863-870, 1997
30. Pettersson K, Gustafsson J: Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 63: 165-192, 2001
31. Tsai M, O'Malley B: Molecular mechanisms of action of steroid/thyroid receptor superfamily. Annu Rev Biochem 63: 451-486, 1994
32. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M: Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors α and β. Cancer Res 62: 4977-4984, 2002
33. Po S, Chen Z, Tsang D, Leung K: Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells. Cancer Lett 187: 33-40, 2002
34. Wang X, Kilgore M: Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma 1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol 194: 123-133, 2002
35. Mueller-Fahrnow A, Egner U: Ligand binding domain of estrogen receptors. Curr Opin Biotech 10: 550-556, 1999
36. Thenot S, Charpin M, Bonnet S, Cavailles V: Estrogen receptor cofactors expression in breast and endometrial human cancer cells. Mol Cell Endocrinol 156: 85-93, 1999
37. Pace P, Taylor J, Sunyharalingam S, Coombes C, Ali S: Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor α. J Biol Chem 272: 25832-25838, 1997